News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ReCor Medical Expands Its Medical Advisory Board


9/28/2012 10:47:08 AM

MENLO PARK, Calif.--(BUSINESS WIRE)--Click here for video interviews

ReCor Medical announced today that it has expanded its medical advisory board in anticipation of conducting post-market clinical studies of its next-generation PARADISE® System for treatment of resistant hypertension via renal denervation—the only system for renal denervation that is based on ultrasound, not radiofrequency, energy. The new medical advisors are: Peter J. Fitzgerald, M.D., Ph.D., Stanford University School of Medicine, Stanford, Calif.; Thomas Mabin, M.D., Vergelegen Medi-Clinic, South Africa; Krishna J. Rocha-Singh, M.D., Praririe Cardiovascular, Springfield, Ill; and Karl-Heinz Kuck, M.D., Ph.D., Asklepios Klinik, Hamburg, Germany.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES